CONTACT

中文

中文

News

PUBLIC NOTICE

USTAR MultNAT MTB/RIF Assay officially approved by the China National Medical Products Administration (NMPA)!

A "Global Solution" for innovating the diagnosis of drug-resistant tuberculosis.

10.09.2025

BUSINESS MOVEMENT

On August 15, 2025, Ustar Biotech and University Indonesia officially signed a Memorandum of Understanding (MoU) in Jakarta

University Indonesia, was founded in 1849. It is the oldest higher education institution in Indonesia and a world-leading research university

10.09.2025

BUSINESS MOVEMENT

Ustar Biotechnology’s Monkeypox Virus Assays Receive WHO Emergency Use Listing (EUL).

The first cerctificate in China, which passed WHO Emergency Use Listing (EUL) approval for the Ustars’ Molecular POC Monkeypox Virus (MPXV ) Assay

10.09.2025

Ustar Biotechnologies (Hangzhou) Ltd.  (Headquarters)

Add: 6/F, Building 2, 611 Dongguan Road, Binjiang District, Hangzhou, Zhejiang, P.R. China

Zip: 310053

Email: sales@bioustar.com

Tel: +86-571-88939358

Copyright Ustar Biotechnologies 2025. All rights reserved

浙ICP备20029265号

Privacy Policy

Terms of Use